UNRESECTABLE ALVEOLAR SOFT PART SARCOMA

Clinical trials for UNRESECTABLE ALVEOLAR SOFT PART SARCOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE ALVEOLAR SOFT PART SARCOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Immune system unleashed to fight rare cancer in new trial

Disease control Ongoing

This study tested whether the immunotherapy drug atezolizumab, alone or with bevacizumab, could help control advanced alveolar soft part sarcoma, a rare cancer. It involved 63 patients with cancer that had spread and could not be removed by surgery. The main goal was to see if th…

Matched conditions: UNRESECTABLE ALVEOLAR SOFT PART SARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

UNRESECTABLE ALVEOLAR SOFT PART SARCOMA

Get alerted when new UNRESECTABLE ALVEOLAR SOFT PART SARCOMA trials appear

Immune system unleashed to fight rare cancer in new trial